Clinical Trials Logo

Mental Processes clinical trials

View clinical trials related to Mental Processes.

Filter by:
  • None
  • Page 1

NCT ID: NCT06309914 Active, not recruiting - Cognitive Change Clinical Trials

The Effects of Mirtoselect®, Virtiva®, and Enovita® on Cognitive Performance and Mood States

Start date: February 21, 2024
Phase: N/A
Study type: Interventional

This is a randomized, double-blind, placebo-controlled, 4-week intervention clinical study assessing the efficacy of Mirtoselect®, Virtiva® Plus, and Enovita® on cognitive performance and mood states, and the occurrence of adverse events in response to daily supplementation. The desired sample size for this study is 64 subjects. To account for potential dropouts, we aim to enroll up to 20% over the desired sample size. Therefore, this study will enroll up to 76 healthy men and women (25-55 years of age). Subjects will be randomly divided into four study groups: Placebo, Virtiva® ginkgo biloba extract, Mirtoselect® bilberry extract, or Enovita® grape seed extract. Blocked randomization will be deployed in which subjects are divided into blocks of 4 subjects and each subject within a block is randomly assigned to one of the four study groups.

NCT ID: NCT05322343 Recruiting - Depression Clinical Trials

Biobank and Brain Health in Bordeaux.

B-cube
Start date: March 22, 2022
Phase:
Study type: Observational [Patient Registry]

B cube is a new generation cohort to study the determinants and natural history of brain aging, using molecular epidemiology, in a representative sample (N=2000) of the general population from the age of 55 (the approximate age of onset of the first cognitive disorders and a target population particularly receptive to prevention messages). Special interest will be given to nutrition, a promising environmental exposure for prevention.

NCT ID: NCT03030053 Active, not recruiting - Mental Processes Clinical Trials

The Effects of Flavonoid Supplementation on Cognition and Neural Mechanisms in Healthy Older Adults

CoCo_Chronic
Start date: February 2016
Phase: N/A
Study type: Interventional

A double-blind, randomised, controlled, parallel arm chronic intervention trial with healthy older adults will be conducted to determine the effect of a flavonoid-rich supplement on cognitive function, peripheral arterial health and brain mechanisms. It is predicted that chronic flavonoid supplementation will result in cognitive benefits and that these may be due to beneficial effects of flavonoids on vascular and brain function.

NCT ID: NCT02935777 Completed - Mental Processes Clinical Trials

Acute Effect of Pomegranate Extract on Cognitive Function

POM-03
Start date: April 2014
Phase: Phase 1
Study type: Interventional

The double-blinded, randomised, placebo-controlled crossover pilot study is conducted as a two week intervention after a pre-intervention registration and preparation period. This study explores whether acute supplementation with pomegranate extract can modulate indicators of cognitive function and mood in healthy adults. Changes in physiological and biochemical markers are also investigated.

NCT ID: NCT01632813 Completed - Critical Illness Clinical Trials

Leuven Growing Into Deficit Follow-up Study

Leuven-GID
Start date: July 2012
Phase: N/A
Study type: Observational

The key objective of the Leuven growing-into-deficit (GID) follow-up-study is to test the hypothesis that children with a congenital heart disease (CHD) show more neurocognitive impairment at the second follow-up at 7 years old than at the first follow-up at the age of 4, compared to healthy controls.